Cyclosporine-associated posttransplant hypertension incidence and effect on renal transplant function
Schorn, T.; Frei, U.; Brackmann, H.; Lorenz, M.; Vogt, P.; Wiese, B.; Pichlmayr, R.; Koch, K.M.
Transplantation Proceedings 20(3 Suppl 3): 610-614
1988
ISSN/ISBN: 0041-1345 PMID: 3291295 Document Number: 314937
Document emailed within 1 workday
Related Documents
Awni, W.M.; Kasiske, B.; Heim-Duthoy, K.; Rose, M.; Rao, V.K.; Bloom, P.; Ney, A.; Andrisevic, J.; Odland, M.; Andersen, R.C. 1988: Changes in the pharmacokinetics of cyclosporine and three of its metabolites in renal transplant patients early in the posttransplant period Transplantation Proceedings 20(2 Suppl. 2): 623-624Hricik, D.E.; Bartucci, M.R.; Moir, E.J.; Mayes, J.T.; Schulak, J.A. 1991: Influence of corticosteroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 1007-1008
Hernández-Infante, E.; García-Martínez, C.; Beltrán-de-la-Luz, S.; Reyes-Acevedo, R.; Romo-Franco, L.; Delgadillo-Castañeda, R.; Orozco-Loza, I.; Chew-Wong, A. 2010: Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: effect on long term allograft survival Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 62(5): 398-405
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263
McCauley, J.; Fung, J.J.; Brown, H.; Deballi, P.; Jain, A.; Todo, S.; Starzl, T.E. 1991: Renal function after conversion from cyclosporine to FK 506 in liver transplant patients Transplantation Proceedings 23(6): 3148-3149
Ernst, C.B.; Daugherty, M.E.; McRoberts, J.W.; Luke, R.G. 1976: Renal transplant arterial stenosis: amelioration of hypertension and improvement of transplant function after revascularization American Surgeon 42(5): 319-325
Ovuworie, C.A.; Fox, E.R.; Chow, C.M.; Pascual, M.; Shih, V.E.; Picard, M.H.; Tolkoff-Rubin, N.E. 2001: Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients Transplantation 72(8): 1385-1388
Jazzar, A.; Fagiuoli, S.; Sisson, S.; Zuhdi, N.; Cooper, D.K. 1994: Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients Transplantation Proceedings 26(5): 2749
Tredger, J.M.; Steward, C.M.; Williams, R. 1988: Blood cyclosporine concentrations in liver transplant recipients: assay method and influence of changed hepatic and renal function Transplantation Proceedings 20(3 Suppl 3: 391-393
Veremis, S.A.; Maddux, M.S.; Tang, I.Y.; Millner, S.N.; Prasad, R.; Pollak, R.; Mozes, M.F. 1989: Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection Transplantation Proceedings 21(1 Part 2): 1476-1477
Yoshimura, N.; Kahan, B.D.; Oka, T. 1991: The in vivo effect of cyclosporine on interleukin-6 gene expression in renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 958-960
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Stahl, R.A.; Kanz, L.; Maier, B.; Schollmeyer, P. 1986: Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine a associated side effect Clinical Nephrology 25(5): 245-248
Landsberg, D.; Rae, A.; Chiu, A.; Werb, R.; Taylor, P.; Chan-Yan, C.; Manson, A.D. 1989: The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation Transplantation Proceedings 21(2): 3323-3324
Ivanovski, N.; Stojceva-Taneva, O.; Grozdanovski, R.; Boskovska, M.; Drueke, T.B.; Massy, Z.A. 2004: Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment Nephrologie 25(7): 301-303
Dieperink, H.; Kemp, E.; Leyssac, P.P.; Starklint, H.; Wanscher, M.; Nielsen, J.; Jørgensen, K.A.; Faber, V.; Flachs, H. 1986: Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine a concentration Clinical Nephrology 25(Suppl 1): S137-S143
Sokal, E.M.; Antunes, H.; Beguin, C.; Bodeus, M.; Wallemacq, P.; de Ville de Goyet, J.; Reding, R.; Janssen, M.; Buts, J.P.; Otte, J.B. 1997: Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus Transplantation 64(10): 1438-1442
Salomon, D.; Brunson, M.; Vansickler, J.; Pfaff, W.; Howard, R.; Peterson, J.; Curry, T.; Thompson, R.; Squiers, E. 1991: A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity Transplantation Proceedings 23(1 Pt 2): 1018-1019
Miwa, H.; Van Loenen, M.; Vanderwerf, B.A. 1989: The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine Clinical Transplants 1989: 275-280
Lager, D.J.; Slagel, D.D.; Burgart, L.J. 1993: Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder Archives of Pathology and Laboratory Medicine 117(3): 308-312